Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats

Brain Research

Volumn 1557, Issue , 2014, Pages 90-100

  Yabuki, Yasushi ^a   Shioda, Norifumi ^a   Maeda, Tomomi ^a   Hiraide, Sachiko ^b   Togashi, Hiroko ^b   Fukunaga, Kohji ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Attention deficit hyperactivity disorder; Cognitive dysfunction; Dopamine D2 receptor; Stroke prone spontaneously hypertensive rats

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; METHYLPHENIDATE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; AMPA RECEPTOR; ENZYME ACTIVATOR; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOPHOSPHORYLATION; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HIPPOCAMPAL CA1 REGION; LEARNING; MALE; MEMORY; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RAT MODEL; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT; Y-MAZE TEST; ANIMAL; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COGNITION DISORDERS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; MAZE TEST; METABOLISM; NEUROPSYCHOLOGICAL TEST; RECOGNITION;

ANIMALIA; RATTUS;

ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CA1 REGION, HIPPOCAMPAL; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ENZYME REACTIVATORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MAZE LEARNING; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; PROTEIN KINASE C; RATS; RATS, INBRED WKY; RECEPTORS, AMPA; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECOGNITION (PSYCHOLOGY);

EID: 84896548168     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.02.025     Document Type: Article

References (71)

1. Alkon, D.L., Sun, M.K., Nelson, T.J., 2007. PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease. Trends Pharmacol. Sci. 28, 51-60. (Pubitemid 46161834)
2. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, 4th ed. American Psychatric Association, Washington DC.
3. Backx, L., Vermeesch, J., Pijkels, E., de Ravel, T., Seuntjens, E., Van, Esch, H, 2010. PPP2R2C, a gene disrupted in autosomal dominant intellectual disability. Eur. J. Med. Genet. 53, 239-243.
4. Barkley, R.A., 1998. Attention-deficit hyperactivity disorder. Sci. Am. 279, 66-71.
5. Bateup, H.S., Svenningsson, P., Kuroiwa, M., Gong, S., Nishi, A., Heintz, N., Greengard, P., 2008. Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat. Neurosci. 11, 932-939.
6. Beaulieu, J.M., Gainetdinov, R.R., 2011. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182-217.
7. Benoit-Marand, M., Borrelli, E., Gonon, F., 2001. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 21, 9134-9141. (Pubitemid 33096856)
8. Berger, D.F., Sagvolden, T., 1998. Sex differences in operant discrimination behaviour in an animal model of attentiondeficit hyperactivity disorder. Behav. Brain Res. 94, 73-82. (Pubitemid 28352466)
9. Borsotto, M., Cavarec, L., Bouillot, M., Romey, G., Macciardi, F., Delaye, A., Nasroune, M., Bastucci, M., Sambucy, J.L., Luan, J.J., Charpagne, A., Jouët, V., Léger, R., Lazdunski, M., Cohen, D., Chumakov, I., 2007. PP2A-bgamma subunit and KCNQ2K+ channels in bipolar disorder. Pharmacogenom. J. 7, 123-132. (Pubitemid 46567144)
10. Carboni, E., Tanda, G.L., Frau, R., Di Chiara, G., 1990. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55, 1067-1070.
11. Castellanos, F.X., Tannock, R., 2002. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 3, 617-628. (Pubitemid 135706670)
12. Collingridge, G.L., Isaac, J.T., Wang, Y.T., 2004. Receptor trafficking and synaptic plasticity. Nat. Rev. Neurosci. 5, 952-962. (Pubitemid 39593358)
13. Conners, C.K., Eisenberg, L., 1963. The effects of methylphenidate on symptomatology and learning in disturbed children. Am. J. Psychiatry 120, 458-464.
14. Cook, E.H., Stein, M.A., Krasowski, M.D., 1995. Association of attention deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56, 993-998.
15. Dash, P.K., Moore, A.N., Kobori, N., Runyan, J.D., 2007. Molecular activity underlying working memory. Learn. Mem. 14, 554-563. (Pubitemid 47347436)
16. Dickinson, S.D., Sabeti, J., Larson, G.A., Giardina, K., Rubinstein, M., Kelly, M.A., Grandy, D.K., Low, M.J., Gerhardt, G.A., Zahniser, N.R., 1999. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72, 148-156. (Pubitemid 29013888)
17. Ernst,M., Zametkin,A.J., Matochik, J.A., Jons, P.H., Cohen, R.M., 1998. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J. Neurosci. 18, 5901-5907. (Pubitemid 28341366)
18. Fan, X., Xu, M., Hess, E.J., 2010. D2 dopamine receptor subtypemediated hyperactivity and amphetamine responses in a model of ADHD. Neurobiol. Dis. 37, 228-236.
19. Fukunaga, K., Goto, S., Miyamoto, E., 1988. Immunohistochemical localization of Ca2+/calmodulin-dependent protein kinase II in rat brain and various tissues. J. Neurochem. 51, 1070-1078.
20. Fukunaga, K., Kobayashi, T., Tamura, S., Miyamoto, E., 1993. Dephosphorylation of autophosphorylated Ca2+/calmodulindependent protein kinase II by protein phosphatase 2C. J. Biol. Chem. 268, 133-137. (Pubitemid 23021295)
21. Fukunaga, K., Shioda, N., Miyamoto, E., 2009. The function of CaM kinase II in synaptic plasticity and spine formation. In: Lajtha, A. (Ed.), Handbook of Neurochemistry and Molecular Neurobiology. Springer, New York, pp. 163-183.
22. Giese, K.P., Fedorov, N.B., Filipkowski, R.K., Silva, A.J., 1998. Autophosphorylation at Thr286 of the alpha calciumcalmodulin kinase II in LTP and learning. Science 279, 870-873. (Pubitemid 28106282)
23. Gizer, I.R., Ficks, C., Waldman, I.D., 2009. Candidate gene studies of ADHD: a meta-analytic review. Hum. Genet. 126, 51-90.
24. Hiraide, S., Ueno, K., Yamaguchi, T., Matsumoto, M., Yanagawa, Y., Yoshioka, M., Togahsi, H., 2013. Behavioral effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/ hyperactivity disorder. Pharmacol. Biochem. Behav. 105, 89-97.
25. Jacob, C., Nguyen, T.T., Weißflog, L., Herrmann, M., Liedel, S., Zamzow, K., Jans, T., Renner, T., Reichert, S., Groß-Lesch, S., Lesch, K.P., Reif, A., 2012. PPP2R2C as a candidate gene of a temperament and character trait-based endophenotype of ADHD. Atten. Deficit Hyperact. Disord. 4, 145-152.
26. Jesmin, S., Togashi, H., Mowa, C.N., Ueno, K., Yamaguchi, T., Shibayama, A., Miyauchi, T., Sakuma, I., Yoshioka, M., 2004a. Characterization of regional cerebral blood flow and expression of angiogenic growth factors in the frontal cortex of juvenile male SHRSP and SHR. Brain Res. 1030, 172-182. (Pubitemid 39574950)
27. Jesmin, S., Togashi, H., Sakuma, I., Mowa, C.N., Ueno, K., Yamaguchi, T., Yoshioka, M., Kitabatake, A., 2004b. Gonadal hormones and frontocortical expression of vascular endothelial growth factor in male stroke-prone, spontaneously hypertensive rats, a model for attentiondeficit/ hypertensive disorder. Endocrinology 145, 4330-4343. (Pubitemid 39120583)
28. Jiang, Y.H., Armstrong, D., Albrecht, U., Atkins, C.M., Noebels, J.L., Eichele, G., Sweatt, J.D., Beaudet, A.L., 1998. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and longterm potentiation. Neuron 21, 799-811. (Pubitemid 28498788)
29. Katz, R.J., Schmaltz, K., 1980. Dopaminergic involvement in attention. A novel animal model. Prog. Neuropsychopharmacol. 4, 585-590. (Pubitemid 11189491)
30. Kempton, S., Vance, A., Maruff, P., Luk, E., Costin, J., Pantelis, C., 1999. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol. Med. 29, 527-538. (Pubitemid 29261342)
31. Knardahl, S., Sagvolden, T., 1979. Open-field behavior of spontaneously hypertensive rats. Behav. Neural. Biol. 27, 187-200. (Pubitemid 10192099)
32. Lahey, B.B., Applegate, B., McBurnett, K., Biederman, J., Greenhill, L., Hynd, G.W., Barkley, R.A., Newcorn, J., Jensen, P., Richters, J., et al., 1994. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am. J. Psychiatry 151, 1673-1685. (Pubitemid 24337603)
33. Lisman, J., Schulman, H., Cline, H., 2002. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat. Rev. Neurosci. 3, 175-190. (Pubitemid 135706588)
34. Liu, X.Y., Chu, X.P., Mao, L.M.,Wang, M., Lan, H.X., Li, M.H., Zhang, G.C., Parelkar, N.K., Fibuch, E.E., Haines, M., Neve, K.A., Liu, F., Xiong, Z.G., Wang, J.Q., 2006. Modulation of D2R-NR2B interactions in response to cocaine. Neuron 52, 897-909. (Pubitemid 44828444)
35. Lou, H.C., Henriksen, L., Bruhn, P., Borner, H., Nielsen, J.B., 1989. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch. Neurol. 46, 48-52. (Pubitemid 19022813)
36. Mehta, M.A., Sahakian, B.J., Robbins, T.W., 2001. Comparative psycholpharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals. In: Solanto, M.V., Arnsten, A.F.T., Castellanos, F.X. (Eds.), Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. Oxford University Press, New York, pp. 303-331.
37. Morón, J.A., Brockington, A., Wise, R.A., Rocha, B.A., Hope, B.T., 2002. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci. 22, 389-395. (Pubitemid 34049076)
38. Myers, M.M., Musty, R.E., Hendley, E.D., 1982. Attenuation of hyperactivity in the spontaneously hypertensive rat by amphetamine. Behav. Neural Biol. 34, 42-54. (Pubitemid 12101057)
39. Nakamura, K., Shirane, M., Koshikawa, N., 2001. Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats. Brain Res. 897, 82-92. (Pubitemid 32244355)
40. Narushima, M., Uchigashima, M., Hashimoto, K., Watanabe, M., Kano, M., 2006. Depolarization-induced suppression of inhibition mediated by endocannabinoids at synapses from fast-spiking interneurons to medium spiny neurons in the striatum. Eur. J. Neurosci. 24, 2246-2252. (Pubitemid 44622345)
41. Nishi, A., Snyder, G.L., Greengard, P., 1997. Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J. Neurosci. 17, 8147-8155. (Pubitemid 27461039)
42. Nogami, T., Beppu, H., Tokoro, T., Moriguchi, S., Shioda, N., Fukunaga, K., Ohtsuka, T., Ishii, Y., Sasahara, M., Shimada, Y., Nishijo, H., Li, E., Kitajima, I., 2010. Reduced expression of the ATRX gene, a chromatin-remodeling factor, causes hippocampal dysfunction in mice. Hippocampus 21, 678-687.
43. Okamoto, K., Aoki, K., 1963. Development of a strain of spontaneously hypertensive rats. Jpn Circ. J. 27, 282-293.
44. Pi, H.J., Otmakhov, N., Lemelin, D., De Koninck, P., Lisman, J., 2010. Autonomous CaMKII can promote either long-term potentiation or long-term depression, depending on the state of T305/T306 phosphorylation. J. Neurosci. 30, 8704-8709.
45. Prickaerts, J., van Staveren, W.C., Sik, A., Markerink-van Ittersum, M., Niewöhner, U., van der Staay, F.J., Blokland, A., de Vente, J., 2002. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 113, 351-361. (Pubitemid 34786180)
46. Rouge-Pont, F., Usiello, A., Benoit-Marand, M., Gonon, F., Piazza, P.V., Borrelli, E., 2002. Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J. Neurosci. 22, 3293-3301. (Pubitemid 35379217)
47. Roskoski Jr., R., 1983. Assays of protein kinase. Methods Enzymol. 99, 3-6. (Pubitemid 13009528)
48. Sagvolden, T., 2000. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci. Biobehav. Rev. 24, 31-39. (Pubitemid 30026144)
49. Sagvolden, T., Berger, D.F., 1996. An animal model of attention deficit disorders: The female shows more behavioral problems and is more impulsive than the male. Eur. Psychologist 1, 113-122.
50. Sagvolden, T., Pettersen, M.B., Larsen, M.C., 1993. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol. Behav. 54, 1047-1055. (Pubitemid 23343120)
51. Sarter, M., Bodewitz, G., Stephens, D.N., 1988. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berl) 94, 491-495. (Pubitemid 18087398)
52. Schmitz, Y., Schmauss, C., Sulzer, D., 2002. Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J. Neurosci. 22, 8002-8009. (Pubitemid 35379105)
53. Sesack, S.R., Hawrylak, V.A., Guido, M.A., Levey, A.I., 1998. Cellular and subcellular localization of the dopamine transporter in rat cortex. Adv. Pharmacol. 42, 171-174.
54. Shioda, N., Beppu, H., Fukuda, T., Li, E., Kitajima, I., Fukunaga, K., 2011. Aberrant calcium/calmodulin-dependent protein kinase II (CaMKII) activity is associated with abnormal dendritic spine morphology in the ATRX mutant mouse brain. J. Neurosci. 31, 346-358.
55. Sykes, D.H., Douglas, V.I., Weiss, G., Minde, K.K., 1971. Attention in hyperactive children and the effect of methylphenidate (ritalin). J. Child Psychol. Psychiatry 12, 129-139.
56. Szatmari, P., Boyle, M., Offord, D.R., 1989. ADHD and conduct disorder: degree of diagnostic overlap and differences among correlates. J. Am. Acad. Child Adolesc. Psychiatry 28, 865-872. (Pubitemid 20031020)
57. Takeuchi, Y., Miyamoto, E., Fukunaga, K., 2002. Activation of the rat dopamine D2 receptor promoter by mitogen-activated protein kinase and Ca2+/calmodulin-dependent protein kinase II pathways. J. Neurochem. 83, 784-796. (Pubitemid 35316028)
58. Tanda, G., Pontieri, F.E., Frau, R., Di Chiara, G., 1997. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci. 9, 2077-2085. (Pubitemid 27485240)
59. Tannock, R., Ickowicz, A., Schachar, R., 1995. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J. Am. Acad. Child Adolesc. Psychiatry 34, 886-896.
60. Terranova, J.P., Chabot, C., Barnouin, M.C., Perrault, G., Depoortere, R., Griebel, G., Scatton, B., 2005. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1 A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology (Berl) 181, 134-144. (Pubitemid 41440924)
61. Togashi,H., Nakamura,K., Matsumoto, M.,Ueno, K.,Ohashi, S., Saito, H., Yoshioka, M., 2002. Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats. Neurosci. Lett. 320, 109-112. (Pubitemid 34164427)
62. Turner, D.C., Blackwell, A.D., Dowson, J.H., McLean, A., Sahakian, B.J., 2005. Neurocognitive effects of methylphenidate in adult attention-deficit/ hyperactivity disorder. Psychopharmacology (Berl) 178, 286-295. (Pubitemid 40379223)
63. Ueno, K.I., Togashi, H., Mori, K., Matsumoto, M., Ohashi, S., Hoshino, A., Fujita, T., Saito, H., Minami, M., Yoshioka, M., 2002. Behavioural and pharmacological relevance of strokeprone spontaneously hypertensive rats as an animal model of a developmental disorder. Behav. Pharmacol. 13, 1-13. (Pubitemid 34174528)
64. Yabuki, Y., Fukunaga, K., 2013. Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress. Neuroscience 250, 394-407.
65. Yabuki, Y., Nakagawasai, O., Moriguchi, S., Shioda, N., Onogi, H., Tan-No, K., Tadano, T., Fukunaga, K., 2013. Decreased CaMKII and PKC activities in specific brain regions are associated with cognitive impairment in neonatal ventral hippocampuslesioned rats. Neuroscience 234, 103-115.
66. Yamori, Y., Horie, R., 1977. Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 8, 456-461. (Pubitemid 8148566)
67. Wang, W.S., Kang, S., Liu, W.T., Li, M., Liu, Y., Yu, C., Chen, J., Chi, Z.Q., He, L., Liu, J.G., 2012. Extinction of aversive memories associated with morphine withdrawal requires ERK-mediated epigenetic regulation of brain-derived neurotrophic factor transcription in the rat ventromedial prefrontal cortex. J. Neurosci. 32, 13763-13775.
68. Weeber, E.J., Jiang, Y.H., Elgersma, Y., Varga, A.W., Carrasquillo, Y., Brown, S.E., Christian, J.M., Mirnikjoo, B., Silva, A., Beaudet, A. L., Sweatt, J.D., 2003. Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J. Neurosci. 23, 2634-2644. (Pubitemid 36418598)
69. Wu, J., Xiao, H., Sun, H., Zou, L., Zhu, L.Q., 2012. Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol. Neurobiol. 45, 605-620.
70. Wultz, B., Sagvolden, T., Moser, E.I., Moser, M.B., 1990. The spontaneously hypertensive rat as an animal model of attentiondeficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav. Neural Biol. 53, 88-102. (Pubitemid 20111365)
71. Xia, Z., Storm, D.R., 2005. The role of calmodulin as a signal integrator for synaptic plasticity. Nat. Rev. Neurosci. 6, 267-276. (Pubitemid 40469981)